Acadia Pharmaceuticals files to sell 43.58M shares of common stock for holders
by
Contributor since / Followers
Contributor since / Followers
1 week ago
- Acadia Pharmaceuticals (NASDAQ:ACAD) files a prospectus for the offer and sale of 43.6M shares of common stock by the selling stockholders.
- This prospectus is not an offer to sell these securities.
- Filing.
More on Acadia Pharma
- ACADIA Pharmaceuticals Inc. (ACAD) Q1 2025 Earnings Conference Call Transcript
- ACADIA Pharmaceuticals Inc. 2025 Q1 – Results – Earnings Call Presentation
- Acadia Pharmaceuticals Ends FY2024 On Solid Footing
- Acad projects $244.3M Q1 revenue with DAYBUE and NUPLAZID growth, anticipates accelerated Prader-Willi trial data
- Acadia Pharma GAAP EPS of $0.11 beats by $0.02, revenue of $244.3M beats by $5.33M